Popularized by the $4 Wal-mart and Target plans. Good news for patients. Bad news for Big Pharma.
The booming generic medication business
ADVERTISEMENT
More in Uncategorized
Past Week
Past 6 Months
-
Rethinking the JUPITER trial and statin safety
-
The ignored clinical trials on statins and mortality
-
How one physician redesigned her practice to find joy in primary care again [PODCAST]
-
I passed my medical boards at 63. And no, I was not having a midlife crisis.
-
Why doctors must fight for a just health care system
-
The silent disease causing 400 amputations daily
-
Recent Posts
-
How Gen Z is reshaping health care through DIY approaches and digital tools [PODCAST]
-
Love and loss in the oncology ward
-
The weight of genetic testing in a family
-
A surgeon’s view on RVUs and moral injury
-
Meeting transgender patients with compassion and equity in health care [PODCAST]
-
Why your health is a portfolio to manage
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
